Repurposing Kinase Inhibitors as Antiviral Agents to Control Influenza a Virus Replication

Assay and Drug Development Technologies - United States
doi 10.1089/adt.2015.0003.drrr
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Antiviral Agents: Reactive Oxygen Species-Regulating Polymersome as an Antiviral Agent Against Influenza Virus (Small 32/2017)

Small
Materials ScienceNanoscienceEngineeringBiomaterialsMedicineBiotechnologyNanotechnologyChemistry
2017English

Repurposing Eukaryotic Kinase Inhibitors as Colistin Adjuvants in Gram-Negative Bacteria

English

Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures

Frontiers in Immunology
AllergyImmunology
2019English

Influenza a Virus Inhibits Influenza Virus Replication by Inducing IL-37

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2018English

Recent Advances in Process Development of Antiviral Agents Targeting the Influenza Virus: Amantadine-RemantadineDerived Pharmaceutical Agents

Open Access Journal of Pharmaceutical Research
2018English

Drug Repurposing Identifies Inhibitors of Oseltamivir-Resistant Influenza Viruses

Angewandte Chemie - International Edition
CatalysisChemistry
2016English

Influenza Virus-Host Interactome Screen as a Platform for Antiviral Drug Development

Cell Host and Microbe
ImmunologyMolecular BiologyCancer ResearchVirologyMicrobiologyMicrobiology Parasitology
2014English

Susceptibilities of Antiviral-Resistant Influenza Viruses to Novel Neuraminidase Inhibitors

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2005English

Tannins as Antiviral Agents

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy